Table 1.
Patient characteristics and cardiovascular morbidity of Turner syndrome patients.
| Patient Characteristics | |
|---|---|
| N | 83 |
| Age (years) | 37.48 ± 11.22 |
| Height (cm) | 154.37 ± 7.04 |
| Body Weight (kg) | 62.06 ± 15.37 |
| BMI (kg/m2) | 25.97 ± 6.00 |
| Underweight (N (%)) | 4 (4.8) |
| Normal weight (N (%)) | 38 (45.8) |
| Overweight (N (%)) | 26 (31.3) |
| Obese (N (%)) | 15 (18.1) |
| Arterial hypertension (N (%)) | 20 (24.1) |
| Drug therapy (N (%)) | 15 (18.1) |
| Glucose metabolism disorders (N (%)) | 4 (4.8) |
| Drug therapy (N (%)) | 4 (4.8) |
| Lipid metabolism disorders (N (%)) | 12 (14.5) |
| Drug therapy (N (%)) | 1 (1.2) |
| Congenital heart disease (N (%)) | 21 (25.3) |
| Cardiac surgery (N (%)) | 11 (13.3) |
| Stroke (N (%)) | 2 (2.4) |
| Smoker (N (%)) | 4 (4.8) |
| Regular cardiological care (N (%)) | 48 (57.8) |
| Regular endocrinological care (N (%)) | 49 (59.0) |
Mean ± standard deviation is used for normally distributed variables. BMI, body mass index. When asked for the presence of cardiovascular disease, 8.4% of TS patients stated unknown for arterial hypertension, 3.6% for glucose metabolism disorders, 13.3% for lipid metabolism disorders and 3.6% for congenital heart disease.